Rosetta Genomics Ltd.

Rosetta Genomics Ltd.

ROSGQ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Rosetta Genomics Ltd.Rosetta Genomics Ltd.0--1298%-2.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.00
Enterprise Value$1.16 Million
Earnings per Share$-9.31
Beta5.34
Outstanding Shares25,459

Return

Return on Equity-1298.18%ROE
Return on Assets-229.85%
Return on Invested Capital-385.20%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue0.21
Enterprise Value to EBIT-0.09
Enterprise Value to Net Income-1
Total Debt to Enterprise2.14
Debt to Equity2.26Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Rosetta Genomics Ltd.

86 employees
CEO: Douglas Sites

Rosetta Genomics Ltd. is a global entity specializing in genomic diagnostics. The company leverages its proprietary microRNA technologies to offer a range of diagnostic assays, including RosettaGX Cancer Origin, which helps pinpoint the ...